bioMérieux S.A. (BMXMF)
BMXMF Stock Price Chart
Explore bioMérieux S.A. interactive price chart. Choose custom timeframes to analyze BMXMF price movements and trends.
BMXMF Company Profile
Discover essential business fundamentals and corporate details for bioMérieux S.A. (BMXMF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
21 Sept 2017
Employees
14.15K
Website
https://www.biomerieux.comCEO
Pierre Boulud
Description
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
BMXMF Financial Timeline
Browse a chronological timeline of bioMérieux S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Mar 2026
Upcoming earnings on 4 Sept 2025
Revenue estimate is $1.08B.
Earnings released on 7 Mar 2025
EPS came in at $1.89 falling short of the estimated $2.23 by -15.25%, while revenue for the quarter reached $2.15B , beating expectations by +99.84%.
Dividend declared on 7 Mar 2025
A dividend of $1.03 per share was announced, adjusted to $1.03. The dividend was paid on 11 Jun 2025.
Earnings released on 30 Oct 2024
EPS came in at $1.95 , while revenue for the quarter reached $2.04B , beating expectations by +1.77%.
Earnings released on 9 Apr 2024
EPS came in at $1.81 , while revenue for the quarter reached $2.09B .
Dividend declared on 14 Mar 2024
A dividend of $0.91 per share was announced, adjusted to $0.93. The dividend was paid on 11 Jun 2024.
Earnings released on 30 Jun 2023
EPS came in at $1.49 , while revenue for the quarter reached $1.93B .
Dividend declared on 12 Apr 2023
A dividend of $0.91 per share was announced, adjusted to $0.91. The dividend was paid on 8 Jun 2023.
Earnings released on 31 Dec 2022
EPS came in at $2.04 , while revenue for the quarter reached $2.08B .
Earnings released on 30 Jun 2022
EPS came in at $2.01 , while revenue for the quarter reached $1.73B .
Dividend declared on 2 Mar 2022
A dividend of $0.91 per share was announced, adjusted to $0.91. The dividend was paid on 8 Jun 2022.
Earnings released on 31 Dec 2021
EPS came in at $3.08 surpassing the estimated $1.91 by +61.26%, while revenue for the quarter reached $2.04B , beating expectations by +13.09%.
Earnings released on 30 Jun 2021
EPS came in at $2.77 surpassing the estimated $2.22 by +24.77%, while revenue for the quarter reached $1.87B , beating expectations by +9.58%.
Dividend declared on 24 Feb 2021
A dividend of $0.75 per share was announced, adjusted to $0.75. The dividend was paid on 8 Jun 2021.
Earnings released on 31 Dec 2020
EPS came in at $2.39 surpassing the estimated $1.70 by +40.59%, while revenue for the quarter reached $2.01B , beating expectations by +10.40%.
BMXMF Stock Performance
Access detailed BMXMF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.